Displaying items by tag: Division of Pulmonary, Allergy and Critical Medicine
ECMO and autoantibody reduction through plasma exchange, experimental therapies not available everywhere, help end an Alabama woman’s five-month medical ordeal.
Tagged under
A two-drug combination therapy for cystic fibrosis is shown to be effective. Triple combination therapy is close behind.
Tagged under
Do you know the warning signs of sepsis? Most Americans don’t … and they should.
Tagged under
A new UAB study will investigate the role of autoantibodies and the benefit of therapeutic plasma exchange on a deadly lung disease.
Tagged under
UAB Hospital continues to be highly ranked by U.S. News and World Report, and is noted as the No. 1 hospital in Alabama.
Tagged under
- school of medicine
- uab hospital
- department of medicine
- division of clinical immunology and rheumatology
- division of nephrology
- division of pulmonary, allergy and critical care medicine
- division of endocrinology, diabetes and metabolism
- division of gerontology, geriatrics, and palliative care
- department of obstetrics and gynecology
- cardiovascular diseases
- Cardiovascular
- department of neurology
- department of neurosurgery
- department of otolaryngology
- department of orthopaedics
A UAB physician will co-chair a steering committee of global cystic fibrosis experts and clinical trial investigators to support the design, conduct and execution of the triple combination pivotal study program.
Tagged under
Physicians at UAB share tips on men’s health and how it affects heart health, sexual function and memory and decreases cancer risk.
Tagged under
Eleven outstanding faculty members were named recipients of the 2017 Dean’s Excellence Awards, an honor recognizing exceptional contributions made by School of Medicine faculty in service, teaching, research, diversity enhancement and mentorship.
Tagged under
- school of medicine
- department of medicine
- division of pulmonary, allergy and critical care medicine
- division of nephrology
- division of preventive medicine
- division of gerontology, geriatrics, and palliative care
- division of clinical immunology and rheumatology
- department of pediatrics
- division of pediatric emergency medicine
- division of pediatric endocrinology
- department of pathology
Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
Tagged under
As lung diseases worsen worldwide, UAB has launched a pre-doctoral training program in pulmonary research that will focus on lung diseases such as asthma, cancer, COPD, cystic fibrosis, pneumonia, lung injury and idiopathic pulmonary fibrosis.
Tagged under